MURPHY JAMES R 4
4 · CPEX Pharmaceuticals, Inc. · Filed Jul 25, 2008
Insider Transaction Report
Form 4
MURPHY JAMES R
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2008-07-22−2,700→ 0 totalExercise: $0.00Exp: 2008-07-22→ Common Stock, $0.01 par value (2,700 underlying) - Exercise/Conversion
Common Stock, $0.01 par value
2008-07-22+2,700→ 45,590 total
Holdings
- 10(indirect: By son)
Common Stock, $0.01 par value
- 1,211(indirect: By 401(k))
Common Stock, $0.01 par value
Footnotes (2)
- [F1]One restricted stock unit represents the right to receive one share of CPEX common stock, $0.01 par value.
- [F2]The vesting and settlement of these awards was accelerated upon the termination of the reporting person's employment with Bentley Pharmaceuticals, Inc. following the closing of its acquisition by Teva Pharmaceutical Industries Ltd. on July 22, 2008.